US Patent No. 8,900,820

Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors
Dec 04, 2014

Nuclea Biotechnologies has been awarded US Patent No. 8,900,820, "Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors."

Patrick Muraca is named as the inventor.

Researchers may experience the effects of the government shutdown for a while, the Los Angeles Times reports.

A new study finds that the majority of patients at a Tijuana clinic received a diagnosis after first-line genome sequencing, the San Diego Union-Tribune reports.

NPR reports that researchers in Italy are testing a gene drive aimed at controlling mosquito populations.

In Genome Biology this week: post-transcriptional modification-based stratification of glioblastoma, single-cell analysis of gene expression and methylation in human iPSCs, and more.